For patients with lung cancer, biomarker testing may be an option.

The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.

Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

On Friday nights, Juan Pedro García Hernández goes dancing – but for rest of the time he’s taking care of his mother.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Targeting inflammation to fight cancer is a new approach with a long history.